obesity drug news today glp-1 october 27 2025 GLP‑1 real‑world data for obesity: A new standard for metabolic care Outlook for Obesity in 2026:

doi:10.3390/ph17020199 8

Primary Tool: Use the #BMI, #waistcircumference, #metabolicsyndrome, #FIB-4 Index (Age, AST, ALT, Platelets) for initial fibrosis risk stratification

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Silveira S.Q., da Silva L.M., de Campos Vieira Abib A., de Moura D.T.H., de Moura E.G.H., Santos L.B., Ho A.M., Nersessian R.S.F., Lima F.L.M., Silva M.V., et al

Critics of GLP-1 therapies often portray those who use these medications as opting for an easy way out to achieve thinness, perpetuating longstanding biases like those historically associated with bariatric surgery (Heitmann, 2025)